This review investigates platelet-related changes by parenteral nutrition lipid emulsions in human studies.
This publication aims to highlight the impact of growth and nutrition on bronchopulmonary dysplasia and highlight research gaps to provide direction for future studies.
This paper highlights the impact of growth and nutrition on bronchopulmonary dysplasia and highlight research gaps to provide direction for future studies.
The purpose is to provide a descriptive analysis of patients who received parenteral nutrition with high mixed lipid and low dextrose content versus parenteral nutrition with lower 100% soybean oil lipid and high dextrose content.
The scope of this review includes the multifactorial pathophysiology of parenteral nutrition–associated liver disease/intestinal failure–associated liver disease as it relates to the pharmaceutical aspects of the various lipid injectable emulsions on the market.
The study compares growth and fatty acids in extremely low birth weight infants who received 100% soybean oil emulsions or multi-oil emulsion with 15% fish oil.
Since there is limited information regarding the use of parenteral nutrition in term and late preterm infants, we analyzed a fifteen-question online survey to study the current clinical practices within Australia and New Zealand.
Parenteral nutrition is a life-saving intervention for patients where oral or enteral nutrition cannot be achieved or is not acceptable. The essential components of parenteral nutrition are carbohydrates, lipids, amino acids, vitamins, trace elements, electrolytes and water.
We examined the clinical utility of a hospital-wide switch to Soybean oil/MCT/Olive/Fish Oil lipid and its effect on patient outcomes.
The aim of this randomized controlled trial is to evaluate the benefits and risks of early
versus late parenteral nutrition in term and late preterm infants.